Deciphering the Mechanistic Landscape of Immune Checkpoint Blockade in ccRCC: From Molecular Drivers to Therapeutic Responses - Takeaways - MDSpire

Deciphering the Mechanistic Landscape of Immune Checkpoint Blockade in ccRCC: From Molecular Drivers to Therapeutic Responses

  • By

  • Ran, Lingxiang

  • Guangmo, Hu

  • Fan, Chunyu

  • Teng, Yuanyin

  • Zhao, Rui

  • Li, Qinghua

  • Jingmin, Yang

  • Zhang, Chao

  • April 28, 2026

  • 0 min

Share

  • 1

    Immune checkpoint inhibitors have significantly improved survival rates in advanced clear-cell renal cell carcinoma.

  • 2

    Patient responses to immune checkpoint inhibitors vary, with primary and acquired resistance posing major challenges.

  • 3

    Tumor-intrinsic factors and the immunosuppressive tumor microenvironment contribute to resistance mechanisms.

  • 4

    Multi-omics approaches are revealing the complex organization of the tumor microenvironment to identify new biomarkers.

  • 5

    Artificial intelligence is enhancing the analysis of multi-omics data to personalize immunotherapy for ccRCC patients.

Original Source(s)

Deciphering the Mechanistic Landscape of Immune Checkpoint Blockade in ccRCC: From Molecular Drivers to Therapeutic Responses

  • by Ran, Lingxiang , Guangmo, Hu , Fan, Chunyu , Teng, Yuanyin , Zhao, Rui , Li, Qinghua , Jingmin, Yang , Zhang, Chao

  • April 28, 2026

Related Content

Bilateral renal metastasis following radical prostatectomy for prostate cancer: a case report

Case Report: Synovial sarcoma with diffuse myxoid stroma and complete absence of epithelial differentiation in the extremity

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation